Skip to main content

Series B Biopharma Companies

Explore 42 biopharma startups that raised series b funding. Access verified founder contact information and fundraising data.

Total Companies
42
Total Funding
$1.5B
Avg Funding
$59.6M
Cities
23

Export 42 Series B Biopharma Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export

NVision Imaging Technologies develops quantum-based medical imaging technology that enhances the capabilities of standard MRI systems.

May 2026
Series B

Founder Contacts

19,000+ verified contacts

Budapest, Hungary
$25.0M
raised

Turbine's platform understands the inner mechanisms of cancer enabling the discovery of novel targets & precision medicinal therapies.

Feb 2026
Series B

Founder Contacts

19,000+ verified contacts

South San Francisco, United States
$254.0M
raised

Kardigan develops personalized medicines using AI and data to target and treat the root causes of cardiovascular diseases.

Oct 2025
Series B

Founder Contacts

19,000+ verified contacts

Portland, United States
$95.0M
raised

Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.

Sep 2025
Series B

Founder Contacts

19,000+ verified contacts

Foster City, United States
$63.0M
raised

AusperBio is a biotechnology company that develops innovative drugs for curing chronic hepatitis B and other major infectious diseases.

Sep 2025
Series B

Founder Contacts

19,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 42 funded startups

19,000+ verified emails
Unlimited exports
No credit card required
Cambridge, United Kingdom
$67.5M
raised

NRG Therapeutics is a drug discovery company focussed on therapeutic approaches that will restore mitochondrial function.

Sep 2025
Series B

Founder Contacts

19,000+ verified contacts

Blue Bell, United States
$3.9M
raised

Seneca is a biotechnology company that focuses on developing novel oncolytic immunotherapeutics for the treatment of cancer.

Aug 2025
Series B

Founder Contacts

19,000+ verified contacts

Saint-antoine, France
$38.9M
raised

BrainEver is a operator of a medical research agency intended to offer drugs for the treatment of neurodegenerative disorders.

Jul 2025
Series B

Founder Contacts

19,000+ verified contacts

Singapore, Singapore
$45.0M
raised

Nuevocor operates as a preclinical-stage biotech company.

May 2025
Series B

Founder Contacts

19,000+ verified contacts

Oakland, United States
$70.0M
raised

Tempero Bio develops treatments for Substance Use Disorders as a clinical-stage biopharmaceutical company.

Mar 2025
Series B

Founder Contacts

19,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 42 funded startups

19,000+ verified emails
Unlimited exports
No credit card required
Boston, United States
$65.0M
raised

Ampersand Biomedicines is a multi-product platform that develops programmable medicines that target disease sites precisely.

Mar 2025
Series B

Founder Contacts

19,000+ verified contacts

Stockholm, Sweden
$27.3M
raised

Drug candidates with a unique mechanism of action, aiming to reduce inflammation and pain. Vipoglanstat to enter phase II for endometriosis.

Jan 2025
Series B

Founder Contacts

19,000+ verified contacts

Sha Tin, Hong Kong

Great Bay Bio is a high-tech company developing blue ocean biopharmaceuticals with a digital CMC platform.

Dec 2024
Series B

Founder Contacts

19,000+ verified contacts

San Diego, United States
$25.0M
raised

Pleno is a biotechnology company that aims speeding up disease diagnosis and treatment.

Dec 2024
Series B

Founder Contacts

19,000+ verified contacts

Oss, The Netherlands
$89.7M
raised

Citryll is a developer of pharmaceutical drugs used to treat autoimmune and other human diseases.

Dec 2024
Series B

Founder Contacts

19,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 42 funded startups

19,000+ verified emails
Unlimited exports
No credit card required
South San Francisco, United States
$84.0M
raised

TRex Bio is a biotechnology company that treats diseases like cancer, fibrotic by studying human tissues.

Nov 2024
Series B

Founder Contacts

19,000+ verified contacts

Monrovia, United States
$120.0M
raised

Terray Therapeutics is a biotechnology company that transforms small molecule drug discovery.

Oct 2024
Series B

Founder Contacts

19,000+ verified contacts

Pohang, South Korea
$5.0M
raised

Bio Design Lab is a biotechnology company that develops biopharmaceutical products.

Oct 2024
Series B

Founder Contacts

19,000+ verified contacts

London, United Kingdom
$28.9M
raised

Resolution Therapeutics is a biopharmaceutical company developing macrophage cell therapy to treat chronic diseases.

Oct 2024
Series B

Founder Contacts

19,000+ verified contacts

Palo Alto, United States
$67.0M
raised

OrsoBio is a clinical-stage biopharmaceutical company that develops therapies to treat severe metabolic disorders.

Sep 2024
Series B

Founder Contacts

19,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 42 funded startups

19,000+ verified emails
Unlimited exports
No credit card required
Tel Aviv, Israel
$80.0M
raised

CytoReason develops a cell-centered computational model of the human body designed to discover complex patterns in biological data.

Jul 2024
Series B

Founder Contacts

19,000+ verified contacts

$10.0M
raised

A leading EU-GMP European vertically integrated Multi-Country Operator company with a global footprint

Jul 2024
Series B

Founder Contacts

19,000+ verified contacts

Philadelphia, United States
$51.4M
raised

Interius BioTherapeutics is a biopharmaceutical company that develops in vivo cell-specific gene medicines to treat B cell lymphomas.

Jun 2024
Series B

Founder Contacts

19,000+ verified contacts

Fishers, United States
$42.9M
raised

INCOG BioPharma services include injectable drug product formulation, analytical method, process scale up, and formulation.

May 2024
Series B

Founder Contacts

19,000+ verified contacts

San Diego, United States
$132.0M
raised

Alterome Therapeutics is a biopharmaceutical company developing alteration-specific targeted therapies.

Apr 2024
Series B

Founder Contacts

19,000+ verified contacts

Showing 1 to 25 of 42 companies

Ready to Connect with Series B Biopharma Startups?

Get verified founder emails, funding details, and company data for 42 series b biopharma companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked